Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa

被引:16
|
作者
Moyo, Faith [1 ]
Chasela, Charles [2 ,3 ]
Brennan, Alana T. [1 ,4 ]
Ebrahim, Osman [5 ]
Sanne, Ian M. [1 ,6 ]
Long, Lawrence [1 ]
Evans, Denise [1 ]
机构
[1] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Unit 2,39 Empire Rd, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Publ Hlth, Epidemiol & Biostat Dept, Fac Hlth Sci, Johannesburg, South Africa
[3] Human Sci Res Council, Epidemiol & Strateg Informat ESI HIV AIDS STIs &, Pretoria, South Africa
[4] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA
[5] Brenthurst Clin, Parktown, South Africa
[6] Right To Care, Helen Joseph Hosp, Johannesburg, South Africa
来源
CLINICAL EPIDEMIOLOGY | 2016年 / 8卷
关键词
health systems; attrition; HIV programs; viral suppression; SUB-SAHARAN AFRICA; EARLY MORTALITY; FOLLOW-UP; CARE; PROGRAM; ADHERENCE; SECTOR; COHORT; INDIA; RISK;
D O I
10.2147/CLEP.S93014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Despite the widely documented success of antiretroviral therapy(ART), stakeholders continue to face the challenges of poor HIV treatment outcomes. While many studies have investigated patient-level causes of poor treatment outcomes, data on the effect of health systems on ART outcomes are scarce. Objective: We compare treatment outcomes among patients receiving HIV care and treatment at a public and private HIV clinic in Johannesburg, South Africa. Patients and methods: This was a retrospective cohort analysis of ART naive adults (>= 18.0 years), initiating ART at a public or private clinic in Johannesburg between July 01, 2007 and December 31, 2012. Cox proportional-hazards regression was used to identify baseline predictors of mortality and loss to follow-up (>3 months late for the last scheduled visit). Generalized estimating equations were used to determine predictors of failure to suppress viral load (>= 400 copies/mL) while the Wilcoxon rank-sum test was used to compare the median absolute change in CD4 count from baseline to 12 months post-ART initiation. Results: 12,865 patients initiated ART at the public clinic compared to 610 at the private clinic. The patients were similar in terms of sex and age at initiation. Compared to public clinic patients, private clinic patients initiated ART at higher median CD4 counts(159 vs 113 cells/mm(3)) and World Health Organization stage I/II(76.1% vs 58.5%). Adjusted hazard models showed that compared to public clinic patients, private clinic patients were less likely to die(adjusted hazard ratio [aHR] 0.50; 95% confidence interval [CI] 0.35-0.70) but were at increased risk of loss to follow-up(aHR 1.80; 95% CI 1.59-2.03). By 12 months post-ART initiation, private clinic patients were less likely to have a detectable viral load(adjusted relative risk 0.65; 95% CI 0.49-0.88) and recorded higher median CD4 change from baseline(184 cells/mm(3) interquartile range 101-300 vs 158 cells/mm3 interquartile range 91-244), when compared to public clinic patients. Conclusion: We identified differences in treatment outcomes between the two HIV clinics. Findings suggest that the type of clinic at which ART patients initiate and receive treatment can have an impact on treatment outcomes. Further research is necessary to provide more conclusive results.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 50 条
  • [21] Urgent need to improve programmatic management of patients with HIV failing first-line antiretroviral therapy
    Sunpath, H.
    Hatlen, T. J.
    Moosa, M-Y S.
    Murphy, R. A.
    Siedner, M.
    Naidoo, K.
    PUBLIC HEALTH ACTION, 2020, 10 (04): : 163 - 168
  • [22] HIV Transmission Risk Behavior Among HIV-Positive Patients Receiving Antiretroviral Therapy in KwaZulu-Natal, South Africa
    Shuper, Paul A.
    Kiene, Susan M.
    Mahlase, Gethwana
    MacDonald, Susan
    Christie, Sarah
    Cornman, Deborah H.
    Fisher, William A.
    Greener, Ross
    Lalloo, Umesh G.
    Pillay, Sandy
    van Loggerenberg, Francois
    Fisher, Jeffrey D.
    AIDS AND BEHAVIOR, 2014, 18 (08) : 1532 - 1540
  • [23] Changes in Risk Behavior Among HIV-Positive Patients During Their First Year of Antiretroviral Therapy in Cape Town South Africa
    Eisele, Thomas P.
    Mathews, Catherine
    Chopra, Mickey
    Lurie, Mark N.
    Brown, Lisanne
    Dewing, Sarah
    Kendall, Carl
    AIDS AND BEHAVIOR, 2009, 13 (06) : 1097 - 1105
  • [24] Starting HIV-positive Babies on Antiretroviral Treatment: Perspectives of Mothers in Soweto, South Africa
    Lazarus, Ray
    Struthers, Helen
    Violari, Avy
    JOURNAL OF PEDIATRIC HEALTH CARE, 2010, 24 (03) : 176 - 183
  • [25] Incidence and predictors of herpes zoster among antiretroviral therapy-naive patients initiating HIV treatment in Johannesburg, South Africa
    Shearer, Kate
    Maskew, Mhairi
    Ajayi, Toyin
    Berhanu, Rebecca
    Majuba, Pappie
    Sanne, Ian
    Fox, Matthew P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 23 : 56 - 62
  • [26] Treatment Outcomes of HIV-Infected Adolescents Attending Public-Sector HIV Clinics Across Gauteng and Mpumalanga, South Africa
    Evans, Denise
    Menezes, Colin
    Mahomed, Kay
    Macdonald, Philippa
    Untiedt, Sanlie
    Levin, Leon
    Jaffray, Imogen
    Bhana, Nainisha
    Firnhaber, Cindy
    Maskew, Mhairi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (06) : 892 - 900
  • [27] Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana
    Chadwick, D.
    Ankcorn, M.
    Sarfo, F.
    Phillips, R.
    Fox, Z.
    Garcia, A.
    Appiah, L.
    Bedu-Addo, G.
    Geretti, A. M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (12) : 2939 - 2942
  • [28] Factors Associated with Retention in HIV Care Among HIV-Positive Adolescents in Public Antiretroviral Therapy Clinics in Ibanda District, Rural South Western Uganda
    Nimwesiga, Christine
    Taremwa, Ivan Mugisha
    Nakanjako, Damalie
    Nasuuna, Esther
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2023, 15 : 71 - 81
  • [29] Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study
    O'Connor, Jemma
    Smith, Colette
    Lampe, Fiona C.
    Johnson, Margaret A.
    Chadwick, David R.
    Nelson, Mark
    Dunn, David
    Winston, Alan
    Post, Frank A.
    Sabin, Caroline
    Phillips, Andrew N.
    LANCET HIV, 2017, 4 (07): : E295 - E302
  • [30] Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy
    McNairy, Margaret L.
    Abrams, Elaine J.
    Rabkin, Miriam
    El-Sadr, Wafaa M.
    PLOS MEDICINE, 2017, 14 (04)